在医药流通行业整体步入存量博弈、线下渠道持续承压的当下,作为中国最大的院外医药产业数字化服务平台,药师帮这一次的业绩值得重点审视。公司全年营收同比增长5.5%,并实现上市以来首次全面盈利;同期,经营性现金流同比增长45%至6.56亿元。行业寒冬中逆势突围的成绩单一出,3月18日药师帮(09885.HK)股价大涨10%+。然而,在整体业绩飘红的表象下,仍有诸多值得探讨的深层命题:净利润转正是否意味着...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.